Published in Front Immunol on December 05, 2016
DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury. Metab Brain Dis (2017) 0.77
The renin-angiotensin system: a possible new target for depression. BMC Med (2017) 0.75
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med (2008) 11.26
Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol (2009) 11.05
Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 7.10
Activation and regulation of the inflammasomes. Nat Rev Immunol (2013) 5.71
Regulation of inflammasome signaling. Nat Immunol (2012) 4.10
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A (2009) 3.99
Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain (2013) 3.87
Interleukin-1 and neuronal injury. Nat Rev Immunol (2005) 3.85
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature (2012) 3.80
Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA (1997) 3.43
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med (2005) 3.42
Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol (2011) 3.42
Surveillance for traumatic brain injury-related deaths--United States, 1997-2007. MMWR Surveill Summ (2011) 3.31
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation (2008) 3.19
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem (2009) 2.90
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell (2012) 2.81
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature (2015) 2.71
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature (2015) 2.67
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63
Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science (2008) 2.53
Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics (2010) 2.52
Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care (2002) 2.48
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol (2008) 2.46
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry (2005) 2.41
beta A4 amyloid protein deposition in brain after head trauma. Lancet (1991) 2.41
Head injury and the risk of AD in the MIRAGE study. Neurology (2000) 2.34
Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? Nat Rev Neurosci (2010) 2.34
Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 2.24
Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science (2014) 2.22
TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell (2015) 2.15
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation (2008) 2.03
The role of markers of inflammation in traumatic brain injury. Front Neurol (2013) 2.01
Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology (1999) 2.00
Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J Cereb Blood Flow Metab (2008) 1.99
The neuropathology and neurobiology of traumatic brain injury. Neuron (2012) 1.99
RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. Nature (2013) 1.98
Head injury in early adulthood and the lifetime risk of depression. Arch Gen Psychiatry (2002) 1.97
Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med (2009) 1.95
Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehabil (2008) 1.94
Head injury and Parkinson's disease risk in twins. Ann Neurol (2006) 1.93
A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci (2008) 1.93
Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci U S A (1999) 1.91
Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology (2003) 1.90
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med (2015) 1.88
Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab (2000) 1.78
Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab (2009) 1.69
The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab (2010) 1.67
Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans (2007) 1.63
Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab (2013) 1.62
Head injury as a risk factor for Alzheimer's disease. Neurology (1985) 1.60
Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci (1995) 1.59
Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol (2014) 1.54
Head injury and amyotrophic lateral sclerosis. Am J Epidemiol (2007) 1.50
P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite. J Neuroinflammation (2015) 1.48
Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int (2004) 1.48
Inflammasomes in the CNS. Nat Rev Neurosci (2014) 1.44
'Hit & Run' model of closed-skull traumatic brain injury (TBI) reveals complex patterns of post-traumatic AQP4 dysregulation. J Cereb Blood Flow Metab (2013) 1.37
Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma (2007) 1.36
Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol (2015) 1.35
New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflammation (2012) 1.34
Innate immunity in Alzheimer's disease. Nat Immunol (2015) 1.33
Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. J Neurotrauma (1994) 1.29
Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J Neurosci (2015) 1.28
Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci (2009) 1.27
Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci (2014) 1.26
ATP release and purinergic signaling in NLRP3 inflammasome activation. Front Immunol (2013) 1.23
APOE genotype influences acquisition and recall following traumatic brain injury. Neurology (2002) 1.21
Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J Cereb Blood Flow Metab (2014) 1.20
Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain (2003) 1.20
Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis. Surg Neurol Int (2011) 1.19
Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis (2013) 1.19
Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma (2002) 1.18
Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst (2004) 1.16
Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol (2003) 1.16
Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J Leukoc Biol (1997) 1.16
Posttraumatic invasion of monocytes across the blood-cerebrospinal fluid barrier. J Cereb Blood Flow Metab (2011) 1.15
Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur J Neurosci (2011) 1.14
CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury. J Neurosci (2015) 1.12
Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues. J Neuroinflammation (2011) 1.12
The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. J Neuroinflammation (2012) 1.12
CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury. Acta Neuropathol (2002) 1.12
Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol (2010) 1.10
Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia (2000) 1.09
The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med (2015) 1.09
Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines. Trends Pharmacol Sci (2015) 1.09
Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiol Dis (2010) 1.08
Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab (2002) 1.07
IL-1 family cytokines trigger sterile inflammatory disease. Front Immunol (2012) 1.07
Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mice. J Neuroinflammation (2012) 1.06
Traumatic brain injury induces macrophage subsets in the brain. Eur J Immunol (2013) 1.06
Epidemiology of traumatic brain injury. Handb Clin Neurol (2015) 1.05
T lymphocyte trafficking: a novel target for neuroprotection in traumatic brain injury. J Neurotrauma (2007) 1.05
Human astrocytes express a novel NLRP2 inflammasome. Glia (2013) 1.05
Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock (2005) 1.04
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects. Neuroscience (2015) 1.03
Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice. J Neurotrauma (2010) 1.03
Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model. Glia (2011) 1.02
TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma (1999) 1.02